Jiuzhitang Co Ltd

Jiuzhitang Co Ltd’s stock price surged 9.97% on August 14, 2025, driven by the company’s innovative drug development, traditional Chinese medicine leadership, removal of risk warnings, and state-owned enterprise status.

Jiuzhitang Co Ltd, a biopharmaceutical company specializing in traditional Chinese medicine, is riding the wave of the industry’s boom, driven by innovative breakthroughs and strategic partnerships.

Jiuzhitang Co Ltd’s stock price has surged to a 52-week high, driven by investor confidence in the company’s innovative traditional Chinese medicines and its strategic focus on treating hepatitis and anemia.